Interventions for lowering plasma homocysteine levels in dialysis patients

Author:

Nigwekar Sagar U1,Kang Amy23,Zoungas Sophia4,Cass Alan35,Gallagher Martin P3,Kulshrestha Satyarth6,Navaneethan Sankar D7,Perkovic Vlado3,Strippoli Giovanni FM89101112,Jardine Meg J313

Affiliation:

1. Harvard Medical School; Division of Nephrology, Massachusetts General Hospital, Scholars in Clinical Sciences Program; Boston MA USA

2. The University of Sydney; Sydney Medical School; Sydney NSW Australia

3. The George Institute for Global Health, The University of Sydney; Renal and Metabolic Division; Camperdown NSW Australia

4. Monash University; Diabetes and Vascular Research Program, Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine; Clayton VIC Australia

5. Menzies School of Health Research; PO Box 41096 Casuarina NT Australia 0811

6. University of Iowa Carver College of Medicine; Department of Nephrology; 200 Hawkins Drive-T307GH Iowa City IA USA 52242

7. Baylor College of Medicine; 1 Baylor Plaza Houston Texas USA 77030

8. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

9. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy

10. Diaverum; Medical Scientific Office; Lund Sweden

11. Diaverum Academy; Bari Italy

12. The University of Sydney; Sydney School of Public Health; Sydney Australia

13. Concord Repatriation General Hospital; Department of Renal Medicine; Hospital Road Concord NSW Australia 2139

Publisher

Wiley

Subject

Pharmacology (medical)

Reference259 articles.

1. The atherosclerosis and folic acid supplementation trial in CRF (ASFAST): rationale, design and baseline results [abstract no: 65];McGrath;Nephrology,2002

2. The atherosclerosis and folic acid supplementation trial in CRF (ASFAST): rationale, design and baseline results [abstract];McGrath;Journal of the American Society of Nephrology,2001

3. The effect of lowering homocysteine on haemodialysis vascular access outcomes: the ASFAST randomised placebo controlled trial [abstract no: SU-FC110];Polkinghorne;Journal of the American Society of Nephrology,2007

4. Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results;Zoungas;Nephrology,2004

5. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD;Zoungas;American Journal of Kidney Diseases,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3